| M & J Monaco Pa | |
|
6716 Congress St New Port Richey FL 34653 | |
| (813) 263-6536 | |
| (813) 741-3480 |
| Full Name | M & J Monaco Pa |
|---|---|
| Speciality | Psychologist |
| Location | 6716 Congress St, New Port Richey, Florida |
| Authorized Official Name and Position | Michael Vincent Monaco (PRESIDENT) |
| Authorized Official Contact | 8132636536 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| M & J Monaco Pa 4142 Mariner Blvd Ste 121 Spring Hill FL 34609-2468 Ph: (813) 263-6536 | M & J Monaco Pa 6716 Congress St New Port Richey FL 34653 Ph: (813) 263-6536 |
| NPI Number | 1073529434 |
|---|---|
| Provider Enumeration Date | 07/31/2006 |
| Last Update Date | 03/22/2024 |
| Certification Date | 03/13/2024 |
| Medicare PECOS PAC ID | 5698870582 |
|---|---|
| Medicare Enrollment ID | O20070423000051 |
News Archive
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
Kathleen Sebelius, the secretary of health and human services, has been visiting the state to encourage private groups to help residents understand what insurance policies and federal subsidies will be available to them when the enrollment period opens Oct. 1.
One of the emerging questions about the coronavirus that scientists are working to understand is why developing countries are showing markedly lower rates of mortality in COVID-19 cases than expected.
VIB landed two research grants worth 1.5 million euros each. The prestigious grants are courtesy of the European Research Council (ERC) and are aimed at giving talented young scientists the opportunity to develop their own research team. The honor fell to Adrian Liston and Patrik Verstreken, both recently transferred to VIB-K.U.Leuven from abroad.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that in a trial of its new Autopheresis-C® software, plasma-center professionals and donors reported faster plasma-collection times and an improved plasma-collection and donation experience. More than 90 percent of donors surveyed reported a decrease in their donation wait time. Donors who are more satisfied are more likely to donate regularly.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073529434 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | (* (Not Available)) | Primary |
| Provider Name | Michael V Monaco |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1629013479 PECOS PAC ID: 5092787325 Enrollment ID: I20061026000214 |
News Archive
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
Kathleen Sebelius, the secretary of health and human services, has been visiting the state to encourage private groups to help residents understand what insurance policies and federal subsidies will be available to them when the enrollment period opens Oct. 1.
One of the emerging questions about the coronavirus that scientists are working to understand is why developing countries are showing markedly lower rates of mortality in COVID-19 cases than expected.
VIB landed two research grants worth 1.5 million euros each. The prestigious grants are courtesy of the European Research Council (ERC) and are aimed at giving talented young scientists the opportunity to develop their own research team. The honor fell to Adrian Liston and Patrik Verstreken, both recently transferred to VIB-K.U.Leuven from abroad.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that in a trial of its new Autopheresis-C® software, plasma-center professionals and donors reported faster plasma-collection times and an improved plasma-collection and donation experience. More than 90 percent of donors surveyed reported a decrease in their donation wait time. Donors who are more satisfied are more likely to donate regularly.
› Verified 3 days ago
News Archive
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
Kathleen Sebelius, the secretary of health and human services, has been visiting the state to encourage private groups to help residents understand what insurance policies and federal subsidies will be available to them when the enrollment period opens Oct. 1.
One of the emerging questions about the coronavirus that scientists are working to understand is why developing countries are showing markedly lower rates of mortality in COVID-19 cases than expected.
VIB landed two research grants worth 1.5 million euros each. The prestigious grants are courtesy of the European Research Council (ERC) and are aimed at giving talented young scientists the opportunity to develop their own research team. The honor fell to Adrian Liston and Patrik Verstreken, both recently transferred to VIB-K.U.Leuven from abroad.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that in a trial of its new Autopheresis-C® software, plasma-center professionals and donors reported faster plasma-collection times and an improved plasma-collection and donation experience. More than 90 percent of donors surveyed reported a decrease in their donation wait time. Donors who are more satisfied are more likely to donate regularly.
› Verified 3 days ago
Ellie Mental Health - Wesley Chapel Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3636 Galileo Drive, Suite 101 And 102, New Port Richey, FL 34655 Phone: 813-714-7587 | |
Kiddos First Autism Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5006 Trouble Creek Rd Ste 218, New Port Richey, FL 34652 Phone: 813-557-9128 | |
Brandi Froebel, Lcsw, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4440 Fort Shaw Dr, New Port Richey, FL 34655 Phone: 813-751-4804 | |
Counseling Resolutions, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7511 Little Rd, Suite 102, New Port Richey, FL 34654 Phone: 727-967-3367 Fax: 727-849-0066 | |
Baycare Life Management-new Port Richey Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4411 Rowan Rd, New Port Richey, FL 34653 Phone: 727-841-4430 | |
Pk Health Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4113 Little Rd, Unit 103, New Port Richey, FL 34655 Phone: 727-376-2880 Fax: 727-816-9745 | |
Advanced Healthcare Alternatives Center For Integrative Medicine And Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5404 Main St, New Port Richey, FL 34652 Phone: 727-849-2277 Fax: 727-597-4789 |